You are here

Nexium

AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million

Forbes

Tue, 10/3/23 - 11:34 am

AstraZeneca hands over some rights to Nexium, Vimovo to Grünenthal as it plots turnaround

Endpoints

Tue, 10/30/18 - 10:24 am

Grünenthal GmbH

The decade's top 10 patent losses, worth a whopping $915B in lifetime sales

Fierce Pharma

Thu, 08/17/17 - 10:36 am

PPI Problems: Heartburn Drugs Associated with Increased Risk of Death

Xtalks

Wed, 07/5/17 - 07:19 pm

proton pump inhibitors

The 19 Best-Selling Prescription Drugs of All-Time

Motley Fool

Mon, 03/13/17 - 11:29 am

Rest easy, pharma. AstraZeneca, Ranbaxy prevailed in landmark pay-for-delay case

Fierce Pharma

Wed, 11/23/16 - 10:23 am

How Could a Potential Nexium Lawsuit Affect AstraZeneca?

Yahoo/GuruFocus

Fri, 11/4/16 - 09:25 am

Dr. Reddy’s to change the color of its generic heartburn drug Nexium

Stat

Mon, 01/4/16 - 12:11 pm

Dr. Reddy's strikes back at AstraZeneca in purple pill courtroom battle

Fierce Pharma

Sat, 11/21/15 - 12:10 pm

AstraZeneca holds on to purple Nexium trademark with early court win

Fierce Pharma Marketing

Wed, 11/11/15 - 09:55 am

AstraZeneca sees red over a ‘purple pill’ and sues a generic drug maker

Pharmalot

Tue, 11/3/15 - 08:51 am

Stalwart brands from AZ, Glaxo and Sanofi top ranks of most-prescribed meds

Fierce Pharma

Mon, 08/17/15 - 11:41 am

Some heartburn drugs linked to increased risk of heart attack

Medical Marketing and Media

Fri, 06/12/15 - 10:47 am

proton pump inhibitors

Small group of branded drugs like Nexium, Copaxone make up huge part of Medicare spend

Fierce Pharma

Sat, 05/2/15 - 01:10 pm

AstraZeneca profit falls as patent expires on heartburn drug

Yahoo/AP

Fri, 04/24/15 - 09:21 am

FDA puts off Mylan's Nexium generic, giving Teva's version free rein

Fierce Pharma

Tue, 02/10/15 - 10:47 am

Teva Pharmaceuticals

Teva's generic version of AstraZeneca's Nexium gets FDA approval

Marketwatch

Mon, 01/26/15 - 06:46 pm

Teva Pharmaceutical

AstraZeneca and Ranbaxy Win a Closely Watched Pay-to-Delay Case

WSJ Pharmalot

Mon, 12/8/14 - 12:13 pm

AstraZeneca Fights Billions in Possible Nexium Damages

Bloomberg

Wed, 12/3/14 - 07:37 am

AstraZeneca Loses Bid to End ‘Pay-For-Delay’ Nexium Trial

Bloomberg

Mon, 11/24/14 - 12:47 pm

Pages